PANews reported on October 13 that according to Businesswire, Nasdaq-listed company ENDRA Life Sciences announced that it has signed a securities purchase agreement. Investors agreed to subscribe for 744,340 shares of common stock and accompanying warrants to purchase up to 1,488,680 shares of common stock. If all warrants are exercised, the company will raise US$14.4 million to support its digital asset treasury. ENDRA Life Sciences previously disclosed that it will implement a Bitcoin-based revenue-generating strategy.
ENDRA Life Sciences plans to raise $14.4 million through a rights offering to bolster its digital asset treasury
Author: PA一线
This content is for informational purposes only and does not constitute investment advice.

Pioneer's View: Crypto Celebrity Interviews
Exclusive interviews with crypto celebrities, sharing unique observations and insights

x402 Protocol: A New Standard for Agent Payments
The x402 protocol aims to solve the core payment dilemma in the AI Agent economy through blockchain technology, providing an autonomous and low-cost on-chain payment solution for high-frequency, small-amount transactions between AI Agents.

PAData: Web3 in Data
Data analysis and visual communication of industry hot spots help users understand the meaning and opportunities behind each data.

A complete review of the 1011 encryption storm
An in-depth review of the epic liquidation events of October 11: from the Trump tariff black swan event to high-leverage margin calls, stablecoin depegging, and market maker liquidity depletion.

ETHShanghai 2025: Discussing the Future of Ethereum
The theme of this conference is "Expanding Ethereum, Shaping an Open Future". It is co-hosted by the Chinese-speaking blockchain builder community ETHPanda, Wanxiang Blockchain Labs, PANews and TinTinLand.

AI Agent: The Journey to Web3 Intelligence
The AI Agen innovation wave is sweeping the world. How will it take root in Web3? Let’s embark on this intelligent journey together

